IVERIC bio, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
IVERIC bio, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q1 2023.
  • IVERIC bio, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2023 was 137M shares, a 18.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 137M +21.3M +18.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 137M +21.4M +18.5% Dec 31, 2022 10-Q 2023-05-10
Q3 2022 121M +16.3M +15.7% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 117M +26.5M +29.3% Jun 30, 2022 10-Q 2022-07-26
Q1 2022 116M +25.8M +28.6% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 115M +25.2M +27.9% Dec 31, 2021 10-K 2023-03-01
Q3 2021 104M +14.7M +16.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 90.4M +898K +1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 90.2M +40.4M +81.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 90.1M +40.5M +81.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 89.6M +48M +115% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 89.5M +48M +116% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 49.7M +8.28M +20% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 49.6M +8.23M +19.9% Dec 31, 2019 10-K 2021-03-04
Q3 2019 41.6M +5.38M +14.9% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 41.5M +5.29M +14.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 41.5M +5.29M +14.6% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 41.4M +5.29M +14.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 36.2M +185K +0.51% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 36.2M +256K +0.71% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 36.2M +343K +0.96% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 36.1M +377K +1.06% Dec 31, 2017 10-K 2019-02-28
Q3 2017 36M +384K +1.08% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 35.9M +421K +1.19% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 35.8M +530K +1.5% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 35.7M +537K +1.53% Dec 31, 2016 10-K 2018-03-05
Q3 2016 35.6M +745K +2.14% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 35.5M +836K +2.41% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 35.3M +1.04M +3.05% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 35.2M +1.2M +3.54% Dec 31, 2015 10-K 2017-02-28
Q3 2015 34.9M +1.32M +3.92% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 34.7M +1.22M +3.66% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 34.2M +921K +2.76% Mar 31, 2015 10-Q/A 2015-07-28
Q4 2014 34M +2.58M +8.22% Dec 31, 2014 10-K 2016-02-26
Q3 2014 33.6M +2.34M +7.47% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 33.5M Jun 30, 2014 10-Q 2014-08-06
Q1 2014 33.3M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 31.4M +29.9M +2037% Dec 31, 2013 10-K/A 2015-07-28
Q3 2013 31.3M Sep 30, 2013 10-Q 2013-11-13
Q4 2012 1.47M Dec 31, 2012 10-K 2014-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.